Genevet, A., Wehr, M.C., Brain, R., Thompson, B.J., and Tapon, N. (2010). Kibra is a
regulator of the Salvador/Warts/Hippo signaling network. Developmental cell 18, 300-308.
Gilkes, D.M., Chaturvedi, P., Bajpai, S., Wong, C.C., Wei, H., Pitcairn, S., Hubbi, M.E.,
Wirtz, D., and Semenza, G.L. (2013). Collagen Prolyl Hydroxylases Are Essential for Breast Cancer
Metastasis. Cancer Res.
Godlewski, J., Nowicki, M.O., Bronisz, A., Nuovo, G., Palatini, J., De Lay, M., Van
Brocklyn, J., Ostrowski, M.C., Chiocca, E.A., and Lawler, S.E. (2010). MicroRNA-451 regulates
LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells. Mol Cell 37, 620-
632.
Godlewski, J., Nowicki, M.O., Bronisz, A., Williams, S., Otsuki, A., Nuovo, G.,
Raychaudhury, A., Newton, H.B., Chiocca, E.A., and Lawler, S. (2008). Targeting of the Bmi-1
oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-
renewal. Cancer research 68, 9125-9130.
101
Gros, J., Serralbo, O., and Marcelle, C. (2009). WNT11 acts as a directional cue to
organize the elongation of early muscle fibres. Nature 457, 589-593.
Grusche, F.A., Richardson, H.E., and Harvey, K.F. (2010). Upstream regulation of the
hippo size control pathway. Current biology : CB 20, R574-582.
Gumbiner, B.M., and Kim, N.G. (2014). The Hippo-YAP signaling pathway and contact
inhibition of growth. Journal of cell science 127, 709-717.
Gusarova, G.A., Wang, I.C., Major, M.L., Kalinichenko, V.V., Ackerson, T., Petrovic, V.,
and Costa, R.H. (2007). A cell-penetrating ARF peptide inhibitor of FoxM1 in mouse
hepatocellular carcinoma treatment. J Clin Invest 117, 99-111.
Halasi, M., and Gartel, A.L. (2009). A novel mode of FoxM1 regulation: positive auto-
regulatory loop. Cell Cycle 8, 1966-1967.
Halasi, M., and Gartel, A.L. (2013). FOX(M1) news--it is cancer. Mol Cancer Ther 12, 245-
254.
Hamaratoglu, F., Willecke, M., Kango-Singh, M., Nolo, R., Hyun, E., Tao, C., Jafar-Nejad,
H., and Halder, G. (2006). The tumour-suppressor genes NF2/Merlin and Expanded act through
Hippo signalling to regulate cell proliferation and apoptosis. Nat Cell Biol 8, 27-36.
Hanahan, D., and Weinberg, R.A. (2000). The hallmarks of cancer. Cell 100, 57-70.
Hanahan, D., and Weinberg, R.A. (2011). Hallmarks of cancer: the next generation. Cell
144, 646-674.
Hao, Y., Chun, A., Cheung, K., Rashidi, B., and Yang, X. (2008). Tumor suppressor LATS1 is
a negative regulator of oncogene YAP. J Biol Chem 283, 5496-5509.
Harvey, K.F., Pfleger, C.M., and Hariharan, I.K. (2003). The Drosophila Mst ortholog,
hippo, restricts growth and cell proliferation and promotes apoptosis. Cell 114, 457-467.
Harvey, K.F., Zhang, X., and Thomas, D.M. (2013). The Hippo pathway and human
cancer. Nat Rev Cancer 13, 246-257.
Hatziapostolou, M., Polytarchou, C., Aggelidou, E., Drakaki, A., Poultsides, G.A., Jaeger,
S.A., Ogata, H., Karin, M., Struhl, K., Hadzopoulou-Cladaras, M., et al. (2011). An HNF4α-miRNA
inflammatory feedback circuit regulates hepatocellular oncogenesis. Cell 147, 1233-1247.
Hergovich, A., Schmitz, D., and Hemmings, B.A. (2006). The human tumour suppressor
LATS1 is activated by human MOB1 at the membrane. Biochemical and biophysical research
communications 345, 50-58.
Hetz, C., Chevet, E., and Harding, H.P. (2013). Targeting the unfolded protein response in
disease. Nature reviews Drug discovery 12, 703-719.
102
Hori, O., Miyazaki, M., Tamatani, T., Ozawa, K., Takano, K., Okabe, M., Ikawa, M.,
Hartmann, E., Mai, P., Stern, D.M., et al. (2006a). Deletion of SERP1/RAMP4, a component of the
endoplasmic reticulum (ER) translocation sites, leads to ER stress. Molecular and cellular biology
26, 4257-4267.
Hori, O., Miyazaki, M., Tamatani, T., Ozawa, K., Takano, K., Okabe, M., Ikawa, M.,
Hartmann, E., Mai, P., Stern, D.M., et al. (2006b). Deletion of SERP1/RAMP4, a component of the
endoplasmic reticulum (ER) translocation sites, leads to ER stress. Mol Cell Biol 26, 4257-4267.
Huang, J., Wu, S., Barrera, J., Matthews, K., and Pan, D. (2005). The Hippo signaling
pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the
Drosophila Homolog of YAP. Cell 122, 421-434.
Huang, X., Ding, L., Bennewith, K.L., Tong, R.T., Welford, S.M., Ang, K.K., Story, M., Le,
Q.-T., and Giaccia, A.J. (2009). Hypoxia-inducible mir-210 regulates normoxic gene expression
involved in tumor initiation. Molecular cell 35, 856-867.
Hunt, S., Jones, A.V., Hinsley, E.E., Whawell, S.A., and Lambert, D.W. (2011). MicroRNA-
124 suppresses oral squamous cell carcinoma motility by targeting ITGB1. FEBS letters 585, 187-
192.
Jaakkola, P., Mole, D.R., Tian, Y.M., Wilson, M.I., Gielbert, J., Gaskell, S.J., von
Kriegsheim, A., Hebestreit, H.F., Mukherji, M., Schofield, C.J., et al. (2001). Targeting of HIF-alpha
to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science
292, 468-472.
Ji, M., Yang, S., Chen, Y., Xiao, L., Zhang, L., and Dong, J. (2012). Phospho-regulation of
KIBRA by CDK1 and CDC14 phosphatase controls cell-cycle progression. The Biochemical journal
447, 93-102.
Jia, J., Zhang, W., Wang, B., Trinko, R., and Jiang, J. (2003). The Drosophila Ste20 family
kinase dMST functions as a tumor suppressor by restricting cell proliferation and promoting
apoptosis. Genes Dev 17, 2514-2519.
Jiao, S., Wang, H., Shi, Z., Dong, A., Zhang, W., Song, X., He, F., Wang, Y., Zhang, Z.,
Wang, W., et al. (2014). A peptide mimicking VGLL4 function acts as a YAP antagonist therapy
against gastric cancer. Cancer Cell 25, 166-180.
Johnson, R., and Halder, G. (2014). The two faces of Hippo: targeting the Hippo pathway
for regenerative medicine and cancer treatment. Nature reviews Drug discovery 13, 63-79.
Kaelin, W.G., and Ratcliffe, P.J. (2008). Oxygen sensing by metazoans: the central role of
the HIF hydroxylase pathway. Molecular cell 30, 393-402.
Kalinichenko, V.V., Major, M.L., Wang, X., Petrovic, V., Kuechle, J., Yoder, H.M.,
Dennewitz, M.B., Shin, B., Datta, A., Raychaudhuri, P., et al. (2004). Foxm1b transcription factor
103
is essential for development of hepatocellular carcinomas and is negatively regulated by the
In document
Proliferation and Survival Mechanisms in Soft Tissue Sarcoma and Glioblastoma Tumors
(Page 109-112)